Authors
Roz Kalb , Psychologist
Close
9 Jan 2024 | ~5:00 Engagement Time
Soon after the diagnosis of MS is confirmed, your MS provider will want to discuss MS disease–modifying therapy (DMTs). These MS treatments, which affect the body’s immune system, modify MS disease activity. They reduce episodes of symptoms, known as relapses, and limit the progression of the disease over time. There are over 20 DMTs for MS, which is a lot to consider when making a treatment decision.
Some people might be inclined to say, “Doctor, please just tell me what to do” – and sometimes this is exactly what happens. Doctors telling us what to do used to be commonplace, but now research tells us that when we are active participants in treatment decisions, our outcomes are better:
The process of making medical decisions collaboratively with your healthcare provider is called “shared decision-making.” In this process, you and your healthcare provider work together to make decisions and select tests, medicines, treatments, and care plans based on clinical evidence that balances risks and expected outcomes with your preferences and values.
Here are a few tips to help you participate in decisions about your MS Disease-Modifying Therapy
We hope these tips will help you participate more comfortably and effectively in the shared decision-making process with your MS care provider. Combining their expertise with your personal goals, values, and priorities is the optimal way to make your treatment work for you.
Keep Learning